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Abstract 
Multiple Sclerosis (MS) is a demyelinating disease of the central nervous system 
(CNS) that leads to severe neurological deficits. Due to their immunomodulatory 
and neuroprotective activities and their ability to promote the generation of 
oligodendrocytes, mesenchymal stem cells (MSCs) are currently being developed 
for autologous cell therapy in MS. As aging reduces the regenerative capacity of 
all tissues, it is of relevance to investigate whether MSCs retain their pro-
oligodendrogenic activity with increasing age. We demonstrate that MSCs derived 
from aged rats have a reduced capacity to induce oligodendrocyte differentiation 
of adult CNS stem/progenitor cells. Aging also abolished the ability of MSCs to 
enhance the generation of myelin-like sheaths in demyelinated cerebellar slice 
cultures. Finally, in a rat model for CNS demyelination, aging suppressed the 
capability of systemically transplanted MSCs to boost oligodendrocyte progenitor 
cell (OPC) differentiation during remyelination. Thus, aging restricts the ability of 
MSCs to support the generation of oligodendrocytes and consequently inhibits 
their capacity to enhance the generation myelin-like sheaths. These findings may 
impact on the design of therapies using autologous MSCs in older MS patients.
Keywords: Aging, multiple sclerosis, cell therapy, mesenchymal stem cells, 
remyelination, oligodendrocytes, CNS stem and progenitor cells. 
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Main Points
Aged MSCs display a reduced oligodendrogenic activity. 
Aging affects the ability of transplanted MSCs to boost OPC differentiation during 
remyelination. 
This study raises concerns regarding autologous MSCs therapies for older MS 
patients.
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Introduction
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the 
central nervous system (CNS), commonly with onset in young adulthood and 
progression throughout life (Reich, Lucchinetti, & Calabresi, 2018). Therefore, the 
prevalence of MS is high in the aging population. In response to demyelination, 
CNS-resident oligodendrocyte progenitor cells (OPCs) become activated, 
proliferate, migrate to the lesion and differentiate into new oligodendrocytes, 
completing remyelination (R. J. M. Franklin & Ffrench-Constant, 2017). While in 
MS and in other demyelinating diseases remyelination occurs efficiently in young 
adults, with aging OPCs’ differentiation and maturation into oligodendrocytes 
declines, becoming a limiting factor for spontaneous remyelination (Sim, Zhao, 
Penderis, & Franklin, 2002). 
Mesenchymal stem cells (MSCs) are undifferentiated multipotent stromal 
cells able to generate osteoblasts, adipocytes as well as chondrocytes, and 
capable of modulating the microenvironment through paracrine signals (Minguell, 
Erices, & Conget, 2001). Therefore, MSCs are viewed as cells with many potential 
clinical applications, in particular as autologous cell therapies (for review see (Ding, 
Shyu, & Lin, 2011)). In the context of MS, MSCs have several potential benefits. 
They are immunomodulatory and can therefore be used to reduce the tissue 
damage resulting from acute inflammatory episodes that are typical for the early 
stages of the disease. Indeed, transplanted MSCs are immunomodulatory and 
neuroprotective promoting functional recovery in MS animal models (Bai et al., 
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2012; Bai et al., 2009) and apparently elicit beneficial effects in human MS patients 
(Connick et al., 2012). 
MSCs’ potential role in myelin regeneration is still being explored. While 
MSCs do not directly transdifferentiate to myelin-producing cells (Hunt et al., 
2008), there is accumulating evidence suggesting that MSCs might beneficially 
influence remyelination by modulating endogenous progenitor activities. We have 
previously demonstrated that soluble factors derived from MSCs induce an 
oligodendrocyte fate on neural stem cells (NSCs) (Rivera F.J. et al., 2006; 
Steffenhagen et al., 2012) and enhance OPC differentiation (Jadasz et al., 2013). 
Furthermore, co-transplantation of NSCs together with MSCs onto organotypic 
hippocampal slice cultures promoted oligodendrocyte differentiation of the 
transplanted NSCs (F. J. Rivera et al., 2009). Also, MSCs grafted into the fimbria 
of cuprizone-induced demyelinated mice significantly activated OPCs and 
supported remyelination (Jaramillo-Merchan et al., 2013). This capacity of MSCs 
to promote oligodendrogenesis is not restricted to rodents as soluble factors 
derived from human MSCs induce oligodendrocyte differentiation in human 
induced pluripotent stem cell-derived NSCs (Jadasz et al., 2018). In summary, 
MSC transplantation might be developed into a potentially powerful MS therapy 
(Connick et al., 2012; Freedman et al., 2010; Jadasz, Aigner, Rivera, & Kury, 
2012). Here we ask whether MSCs retain their capacity to enhance the generation 
of new oligodendrocytes with aging. 
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2-month-old and 17 to 20 months-old male and female Fischer 344 rats 
(Charles River Deutschland GmbH, Germany) were used as young and old 
donors, respectively, for MSC cultures. Demyelinating surgeries were performed 
in 12-month-old male Fisher 344 rats (Harlan, UK) according to Home Office 
regulations. P0-P2 Sprague-Dawley rats (Internal Breeding Stock, University of 
Cambridge) were used for OPC cultures. Animal experiments within this research 
have been regulated under the Animals (Scientific Procedures) Act 1986 
Amendment Regulations 2012 following ethical review by the University of 
Cambridge Animal Welfare and Ethical Review Body (AWERB) in accordance with 
UK Home Office regulations (Project License: 70/7715).
MSC cultures
MSC cultures from young and old rats were performed as previously 
described (F. J. Rivera et al., 2008). Briefly, bone marrow (BM) plugs were 
harvested from femurs and tibias of young (y; 2-month-old) and old (o; 17 to 20-
month-old) male and female Fisher-344 rats (Charles River Deutschland GmbH, 
Germany). Plugs were mechanically dissociated in αMEM (Gibco Invitrogen, 
Karlsruhe, Germany) and recovered by centrifugation. Cell pellets were 
resuspended in αMEM containing 10% FBS (PAA, Austria) and 1% Penicillin / 
Streptomycin (PAN Biotech GmbH, Aidenbach, Germany) (αMEM-10% FBS) and 
seeded at 1x106 cells/cm2. After 3 days, medium was changed, and non-adherent 
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cells were removed. Adherent cells were incubated in fresh αMEM-10% FBS until 
a confluent layer of cells was achieved. Cells were trypsinized using 0.25% Trypsin 
(Gibco Invitrogen, Karlsruhe, Germany) and seeded in αMEM-10% FBS at 8,000 
cells/cm2. After 3-5 days of culture, the resulting monolayer of cells, hereafter 
named rat bone marrow-derived mesenchymal stem cells (MSCs), was trypsinized 
and further cultured for experiments or frozen for later use. As demonstrated in our 
previous work, this cell culture preparation is highly enriched in multipotent MSCs 
with no more than 4,5% of hematopoietic contamination (Rivera F.J. et al., 2006). 
We named yMSCs when cells were isolated from young rats (2-month-old) and 
oMSCs (17 to 20-month-old) when were isolated from old animals.
NSC cultures
Tripotent NSCs derived from rat hippocampus were generated as described 
(Wachs et al., 2003). Briefly, hippocampi from 2-month-old male and female 
Fisher-344 rats (Charles River Deutschland GmbH, Germany) were aseptically 
removed and dissociated. Cells were resuspended in Neurobasal-A medium (NB-
A) (Gibco BRL, Germany) supplemented with B27 (Gibco BRL, Germany), 2 mM 
L-glutamine (PAN, Germany), 100 U/ml penicillin / 0.1 mg/l streptomycin (PAN, 
Germany), hereafter referred to as NB/B27. For maintenance and expansion of the 
cultures, the NB/B27 was further supplemented with 2mg/ml heparin (Sigma, 
Germany), 20 ng/ml FGF-2 (R&D Systems, Germany) and 20 ng/ml EGF (R&D 
Systems, Germany). As previously described (Rivera F.J. et al., 2006), 
immediately after plating of dissociated neurospheres in NB/B27-5% FBS, around 
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90% of the NSCs expressed the neural stem and progenitors markers such as 
nestin and A2B5. Cultures were maintained at 37°C in a humidified incubator with 
5% CO2. Neurosphere cultures from passage number 2 to 6 were used throughout 
this study and termed NSCs. 
OPCs Cultures
OPCs were obtained from P0-P2 Sprague-Dawley rats (Internal Breeding Stock, 
University of Cambridge). Briefly, purified OPCs were obtained following the 
protocol of McCarthy and De Vellis. Cells from the cortex and hippocampus were 
dissociated and cultured in the presence of DMEM (Gibco, Carlsbad, CA) 
containing 1% P/S (Sigma Aldrich, Buchs, Switzerland) and 10% fetal bovine 
serum (FBS, Biosera, Boussens, France) on poly-D-lysine coated flasks. After 10-
12days of mix glial cultures OPCs were mechanically dissociated from other glial 
cell types (McCarthy & de Vellis, 1980). OPCs were isolated shaking off loosely 
adherent cells from the astrocyte adherent cell monolayer. The supernatant 
(enriched in OPCs) was collected and microglial cells were removed by incubation 
in plastic Corning petri dishes (BD, Oxford, UK) 15min at 37°C. As previously 
described, this procedure results in a relatively pure population of OPCs (de la 
Fuente et al., 2015). Indeed, we determined that 92 +/- 4% of total cells were Olig2-
expressing undifferentiated OPCs. These cells are positive for the oligodendroglial 
lineage marker Olig2 and negative for the expression of mature oligodendrocyte 
markers, such as MBP and CNPase. OPCs were re-suspended and plated in 
13mm poly-D-lysine (5µg/mL) pre-coated coverslips (Thermo Scientific, Waltham, 
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MA) in serum free Sato media (DMEM supplemented with 0.3mg/mL BSA fraction 
V (Sigma Aldrich), 0.1mg/mL progesterone, 1.61mg/mL putrescine, 25µg/mL 
sodium selenite, 1% P/S 50µg/ml of holo-Transferrin (Sigma Aldrich) and 5µg/ml 
of insulin (Gibco)). OPCs were cultured in Sato media supplemented with 10ng/ml 
of PDGF-AA and 10ng/ml bFGF (Peprotech, Rocky Hill, NJ) to keep the cells in 
the proliferative stage. 
Organotypic cerebellar slices cultures
Demyelinating rat cerebellar slice cultures were prepared as previously 
described (Birgbauer, Rao, & Webb, 2004). Briefly, P9 rat cerebellum was isolated 
and 300µm sections were obtained using McIlwain tissue chopper (McIlwain, San 
Antonio, TX). Slices were then incubated at 37ºC with 5% CO2 in organotypic slice 
medium (50% BME (Gibco), 25% heat inactivated horse serum (Gibco), 25% 
HBSS (BME) (Gibco), 5mg/mL glucose, 1X glutamax (Gibco) and 1X Mycozap-PR 
plus (Lonza)). After a week in culture, slices were demyelinated with 0.5mg/mL 
lysolecithin for 16h and then incubated in lysolecithin-free medium to allow 
remyelination. 
Growth curve and cell number determination 
yMSCs and oMSCs from different passage number were plated at 5,000 
cells per cm2 and incubated in MSCs proliferation medium (αMEM-10% FBS). The 
correct number of seeded cells was immediately confirmed using CASY-Cell 
Counter (Roche, Vienna Austria). Cells were incubated up to one week in αMEM-
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10% FBS. After 1, 3, 5 and 7 days incubation cells were detached with 0.25% 
Trypsin (Gibco BRL, Karlsruhe), collected in falcon tubes, centrifuged at 600 x g 
for 10 minutes and the cell pellet was resuspended in 1 ml αMEM-10% FBS. 250 
µl of each cell suspension was dissolved in CASYTON (Roche, Vienna Austria) 
and cell number was determined with CASY-Cell Counter (Roche, Vienna Austria). 
Measurements with CASY-Cell Counter were performed using the following 
settings: Dilution: 2.000e +00, Capillary: 150 µm, X-Axis: 30 µm, Sample Volume: 
400 µl, Cycles: 3, Eval. Cursor: 9.00-30.00 µm, Norm. Cursor 15-30.00 µm.
Mesenchymal stem cell conditioned media (MSC-CM) preparation
For experiments performed in NSCs, mesenchymal stem cell conditioned 
medium (MSC-CM) was prepared as described (Rivera F.J. et al., 2006). Briefly, 
yMSCs or oMSCs were plated at 12,000 cells/cm2 and incubated in MSC 
proliferation medium (αMEM-10% FBS). For experiments performed in OPCs, 
yMSCs or oMSCs were incubated with serum free Sato media (DMEM 
supplemented with 0.3mg/mL BSA fraction V (Sigma Aldrich), 0.1mg/mL 
progesterone, 1.61mg/mL putrescine, 25µg/mL sodium selenite, 1% P/S 50µg/ml 
of holo-Transferrin (Sigma Aldrich) and 5µg/ml of insulin (Gibco)) without PDGF-
AA and bFGF. For experiments performed in demyelinated cerebellar slices, 
yMSCs or oMSCs were incubated with organotypic slice culture medium (50% 
BME (Gibco), 25% heat inactivated horse serum (Gibco), 25% HBSS (BME) 
(Gibco), 5mg/mL glucose, 1X glutamax (Gibco) and 1X Mycozap-PR plus (Lonza). 
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Conditioned media was collected after 3 days in vitro and filtered through a 
0.22µm-pore filter. 
Bioluminescence assays
Bioluminescence assays were performed using non-commercial dual 
luciferase enzyme assay system. In this system, NSCs were co-transfected with: 
1) plasmid containing MBP promoter driving the expression of Firefly luciferase 
(pMBP-Luci); 2) control vector that contains the cytomegalovirus (CMV) promoter 
driving the expression of Renilla luciferase (Promega, Mannheim, Germany). The 
two different luciferases use different specific substrates and therefore, the MBP 
regulatory region driven Firefly luciferase activity was distinguished from Renilla 
luciferase. Transfected NSCs were seeded in Poly- L- Ornithine/Laminin-coated 
dishes in white-96-well plates and incubated either under control condition (αMEM-
10% FBS) or in different MSC-CM dilutions. After 3 days NSCs were exposed to 
lysis solution that contained 25 mM Tris-phosphate pH 7.8, 2 mM DTT, 1% Triton 
X-100 (Sigma-Aldrich, Taufkirchen, Germany), 2 mM EDTA, 10% Glycerol (Merck, 
Darmstadt, Germany). To analyze the Firefly luciferase activity cell lysate was 
treated with the following buffer: 25 mM glycylglycine (Acros, Geel, Belgium) 15 
mM KxPO4 pH 8.0, 4 mM EGTA, 15 mM MgSO4, (Merck, Darmstadt, Germany), 
2 mM ATP, 1 mM DTT, 0.1 mM Coenzym A, 75 mM luciferin (Sigma-Aldrich, 
Taufkirchen, Germany). To analyze the Renila luciferase activity cell lysate was 
treated with the following buffer: 1.1 M NaCl (VWR, Vienna, Austria), 2.2 mM 
Na2EDTA, 0.22 M KxPO4 pH 5.1 (Merck, Darmstadt, Germany), 0.44 mg/mL BSA 
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(Biomol, Hamburg, Germany), 1.3 mM NaN3 (Sigma-Aldrich, Taufkirchen, 
Germany), 1.43 mM coelenterazine (P.J.K., Kleinblittersdorf, Germany). 
Bioluminescence was measured by Luminometer (Tristar LB 941, Berthold 
Technologies, HVD, Austria) and luciferase activity was determined. In all 
conditions Firefly luciferase activity was normalized against the Renilla luciferase 
activity.
NSCs, OPCs and demyelinated cerebellar slices stimulation with yMSC-CM 
and oMSC-CM
 NSCs were treated with yMSC-CM and oMSC-CM as previously described 
(Rivera F.J. et al., 2006). Briefly, NSCs were plated overnight onto poly-ornithine 
(250 µg/mL) and laminin (5 µg/mL)-coated glass coverslips at a density of 12,000 
cells/cm2 in αMEM-10% FBS. Next, media was replaced and cells were incubated 
either with yMSC-CM or oMSC-CM. NSCs were alternatively incubated in αMEM-
10% FBS as control condition. Media was changed every third day of incubation. 
After one week of incubation, or alternatively after three days in the luciferase 
experiments, cells were fixed for 30 minutes with phosphate-buffered 4% 
paraformaldehyde (Sigma-Aldrich, Taufkirchen, Germany) and processed either 
for immunofluorescence, or for bioluminescence analysis, respectively. 
OPCs were treated with yMSC-CM and oMSC-CM. OPCs were plated in 
13mm poly-D-lysine pre-coated coverslips (Thermo Scientific) at a density of 
30000 cells per cm2. Cells were incubated for three days in Sato-based serum free 
media supplemented daily with 10ng/ml of PDGF-AA and 10ng/ml bFGF to keep 
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the cells in the proliferative stage. Next, media was switched to Sato-based yMSC-
CM or oMSC-CM in the absence of growth factors. OPCs were alternatively 
incubated in Sato media without growth factors as control condition. Media was 
replaced every two days and OPCs were fixed with phosphate-buffered 4% 
paraformaldehyde (pH 7.4) at 2 and 4 days of incubation and cells were processed 
for immunofluorescence.
After exposure to lysolecithin, demyelinated cerebellar slices were 
incubated with organotypic slice medium-based yMSC-CM or oMSC-CM. 
Unconditioned organotypic slice medium was used as control. Treatment was 
replaced every other day and slices were collected at 2 and 6 days in vitro (DIV) 
post demyelination and fixed with 4% PFA for 1h. Then slices were stored in PBS 
1X at -20ºC for immunostaining. 
Immunocytochemistry and analysis
Fixed NSCs were washed in TBS (0.15 M NaCl, 0.1 M Tris-HCl, pH 7.5), 
then blocked with solution composed of TBS; 0.1% Triton-X100 (only for 
intracellular antigens); 1% bovine serum albumin (BSA) and 0.2% Teleostean 
gelatin (Sigma, Germany) (fish gelatin buffer, FGB). The same solution was used 
during the incubations with antibodies. Primary antibodies were applied overnight 
at 4°C. Fluorochrome-conjugated species-specific secondary antibodies were 
used for immunodetection. The following antibodies and final dilutions were used. 
Primary antibodies: rabbit anti-GFAP 1:1000 (Dako, Denmark); mouse anti-Myelin 
Basic Protein (MBP) 1:750 (SMI-94, Covance, Anopoli Biomedical Systems, 
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Eichgraben, Austria); rabbit. Secondary antibodies: donkey anti-mouse, rabbit 
conjugated with Alexa Fluor 488, Alexa 568 1:1000 (Molecular Probes, Eugene, 
OR, USA). Nuclear counterstaining was performed with 4´, 6´-diamidino-2-
phenylindole dihydrochloride hydrate at 0.25 μg/μl (DAPI; Sigma, Germany). 
Specimens were mounted on microscope slides using in Prolong Antifade kit 
(Molecular Probes, U.S.A.). Epifluorescence observation and photo-
documentation were realized using an Olympus IX81 microscope (Olypmpus, 
Germany) equipped with Hamamatsu digital camera and Volocity software (Perkin 
Elmer, Germany).  For each culture condition, 5 to 10 randomly selected 
observation fields, containing in total 500-1,000 cells, were photographed for cell 
fate analysis. Expression frequency of selected cell type markers was determined 
for every condition in four independent experiments.
Fixed OPCs were washed in phosphate-buffered saline (PBS) before blocking. 
Next, cells were blocked with 5% normal donkey serum (Sigma, UK) and 0.1% 
triton (Sigma, UK) in PBS for 1 hour at room temperature. The same solution was 
used during the incubation with antibodies. Primary antibodies were applied 
overnight at 4°C (rat anti- Myelin Basic Protein (MBP) 1:500 (Serotec), mouse anti- 
CNPase 1:400 (Abcam, UK) and goat anti- Olig2 1:200 (Abcam, UK). After three 
washes with PBS florochrome-conjugated species-specific secondary antibodies 
(488 anti- Goat 1:300 and Alexa fluor 568 anti- rat 1:500 or Alexa Fluor 647 anti-
mouse 1:500 (Life technologies, UK) were used for 2h at room temperature to 
detect primary antibodies. Nuclear counterstaining was performed with Hoechst 
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2µg/mL (Sigma Aldrich). Epifluorescence observation and photo-documentation 
were realized using an Olympus IX81 microscope (Olypmpus, Germany) equipped 
with Hamamatsu digital camera and Volocity software (Perkin Elmer, Germany). 
Percentage of cells expressing Olig2 that also expressed the other mature OPC 
markers was determined in at least three independent experiments. 
Focal demyelination lesions 
Male Fischer 344 rats aged 12 months were used to induce bilateral focal 
demyelination in the caudal cerebellar peduncle (CCP) in compliance with UK 
Home Office regulations (Project License: 70/7715, formerly 80/2228). Animals 
were anesthetized using a combination of 2% isoflurane in oxygen (as carrier gas) 
and a subcutaneous injection of buprenorphine hydrochloride 0.03 mg/kg 
(Vetergesic, Animalcare Ltd, Hull, UK). The procedure consisted on bilateral 
stereotactical injections of 4µL of 0.01% ethidium bromide (v/v) into the CCP, 
−11.6 mm caudal, ±2.9 mm lateral, and −8.3 mm ventral from bregma (Woodruff & 
Franklin, 1999). 
MSCs stable transfection with mCherry
PiggyBac transposon-based strategy was used for MSCs stable transfection 
with mCherry (Yusa, Zhou, Li, Bradley, & Craig, 2011). The coding region of 
mCherry was amplified by PCR and cloned into the XbaI / EcoRI sites of the 
backbone PiggyBac vector PB-CMV-MCS-EF1-Puro (System Biosciences; Cat. 
No. PB5105B-1). For further genomic integration the following vector was used: 
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pCMV-hyPBase (provided by the Wellcome Trust Sanger Institute). MSCs 
obtained from 2 and 20 months old male rats were transfected with PB-CMV-
mCherry-EF1-Puro and pCMV-hyPBase plasmids. Amaxa® Basic Nucleofector® 
Kit for Primary Mammalian Smooth Muscle Cells (Lonza) and the program U-023 
were used to transfect 5 x 106 cells with 4g of PB-CMV-mCherry-EF1-Puro and 
1g of pCMV-hyPBase. This methodology allowed approximately 40% of 
transfection efficiency. For further selection, transfected cells were incubated in 
the presence of 2g/ml puromycin (Sigma) for at least 1 week, leading to a highly 
pure mCherry-expressing MSCs culture. 
MSCs transplantation into demyelinated rats
mCherry-expressing MSCs were intravenously transplanted into rats after 
CCP demyelination. To reduce the probability of transplant rejection, we used male 
Fisher 344 (inbred strain) rats as MSCs donors and transplanted host. Previous to 
transplantation, cultured mCherry-expressing MSCs were collected in PBS at a 
suspension of 2.0 x 106 cells / ml with a survival rate of 80 – 98%. Three daily 
doses of 1.5 – 2.0 x 106 mCherry-expressing MSCs obtained from young and old 
donors were administrated through the tail vein of previously demyelinated rats at 
1, 2 and 3 days post lesion (dpl) induction. Tail vein infusion of PBS (1 ml) was 
used as vehicle control group. 4 – 5 animals were considered per group. Animals 
were then perfused/fixed with 4% PFA at 21 dpl. Fixed brains were kept in 20% 
sucrose and embedded in optimal cutting temperature compound (Taab). 
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Cryosections were obtained using a cryostat (Bright Instruments, Luton, 
Bedforshire) at 12 µm thickness and then frozen at −80°C until further processing.
Immunohistochemistry
Fixed cerebellar slices were washed in phosphate-buffered saline (PBS) and 
blocked for 1h with 10% NGS 0.5% Triton X-100 in agitation and incubated 
overnight with antibodies for MBP (1:500, Serotec, Kidlington, UK) and NFH 
(1:500, Abcam, Cambridge, UK) in blocking solution. Slices were washed three 
times with PBS and 0.1% Triton X-100. Slices were incubated with fluorochrome 
conjugated secondary antibodies (AF488, AF568, 1:300, Invitrogen) for 2h at 20-
26ºC. The secondary antibodies were removed washing with PBS 0.1% Triton X-
100 and then Hoechst (1µg/mL final concentration, Sigma) was used for nuclei 
staining. Slices were mounted with Fluoromount G onto poly D- lysine slides, 
covered with a 20mm coverslip (VWR, Radnor, PA) and prepared for confocal 
microscopy visualization and documentation.
12-µm sections were dried for 1h at RT and washed with PBS. Only for Olig2 
/ APC stainings, antigen retrieval was performed by incubating the sections for 10 
min at RT with pre-boiled 1× citrate buffer, pH 6.0 and antigen retriever (Dako). No 
antigen retrieval was performed for mCherry stainings. Then, slides were 
incubated for 2h at RT with blocking solution (5% normal donkey serum and 0.1% 
Triton X-100). After blocking, slices were incubated with primary antibodies 
overnight at 4ºC, washed and incubated with secondary antibodies for 2 hours at 
RT in blocking solution.  Nuclei were stained with 1 µg/ml Hoechst for 5 min, and 
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slides were mounted after washes with Fluoromount G. Primary antibodies: rabbit 
anti-Olig2 antibodies (1:200; R&D Systems), mouse anti-APC (1:200; EMD 
Millipore), rabbit anti-Ki67 (1:500; Abcam), mouse anti-Nkx2.2 (1:100; 
Developmental Studies Hybridoma Bank), goat anti-Iba1 (1:500; Abcam), rabbit 
anti-mannose receptor (MR) (1:200; Abcam), rabbit anti-Periaxin (1:1000; from 
Peter Brophy, Centre for Neuroscience Research, University of Edinburgh, UK) 
and rabbit anti-mCherry (1:200; Abcam). Fluorochrome conjugated secondary 
antibodies: Donkey AF488 anti-rabbit (1:500; Invitrogen), Donkey AF488 anti-goat 
(1:500; Invitrogen), Donkey AF568 anti-rabbit (1:500; Invitrogen) and Donkey 
AF647 anti-mouse (1:500; Invitrogen). 
Histological analysis and quantification
For the quantification and analysis of slices derived from the ex vivo 
organotypic culture, four independent slices were analyzed per condition and per 
experiment. Five images of randomly chosen areas of each slice were imaged 
using Leica SP5 confocal microscope 40X objective (NA 1.25) with 1.5 digital 
zoom, 1024x1024 resolution and 1.75 to 2µm thickness stacks. Slices derived from 
the same animal were count as n=1 and the different biological experiments were 
count as independent experiment (individual n). For analysis, a macro was created 
in Image J, which measured the MBP-NFH colocalization area and the total NFH 
area.
For in vivo experiments, CCP lesions were recognized by the presence of 
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increased cellularity denoted by Hoechst staining. For the quantification and 
analysis of the CCP lesion images, the whole lesion of three sections was imaged 
per animal with the 20× objective (NA 0.70), 1,024 × 1,024 resolution, and 1.5–2-
µm stacks. This was performed for each CCP lesion (left and right) per animal. 
Using ImageJ software, the lesion area was delineated based on Hoechst channel 
as mentioned previously and measured. Then the number of different cell types 
OPCs (Olig2+/APC-), proliferating OPCs (Nkx2.2+/Ki67+), mature 
oligodendrocytes (Olig2+/APC+) and Schwann cells (Periaxin+) within the lesion 
was counted manually with the cell counter plugin. The number of macrophages / 
microglia cells (Iba1+ and MR+) was quantified using ImageJ software by applying 
the following constant parameters of brightness/ contrast, threshold, particle size 
and circularity, respectively:  0/255, 75/255, 20 – 350, 0 – 40 (for Iba1) and 0/185, 
45/255, 60 – 350, 0.05 – 40 (for MR). All the images were acquired at room 
temperature.
Oil Red-O staining
Sections from control and treatment group were left to dry at room temperature 
and then placed in a Coplin jar containing propylene glycol (100%) for 5 min. 
Prewarmed Oil Red-O solution (0.5% in propylene glycol, Sigma-Aldrich) was 
stained at 65°C for 10 min. Following incubation for 5 min with differentiation 
solution (85% propylene glycol), slides were rinsed twice with water and then 
mounted using a jelly-based mounting media. Representative images of Oil Red-
O stained lesions were digitized, and, using ImageJ software, the intensity of the 
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lesion area was measured from the red channel. Data are given as mean ± SEM 
and statistically analyzed. Three sections per marker per animal were analyzed, 
and a minimum of four animals were used.
Statistical analysis  
Data are presented as means ± SD and statistical analysis was performed 
using PRISM4 (GraphPad, San Diego, CA, USA) and SPSS (IBM, Headquarters). 
P values of < 0.05 were considered to be significant acquired by parametric one-
way ANOVA and Tukey post hoc. For MSCs growth curve and MSC-CM dose-
dependent experiments, two-way ANOVA and Bonferroni post hoc were 
performed. For experiments carried out in organotypic slices, two-way ANOVA and 
Bonferroni post hoc were performed. For in vivo remyelination studies, 4 - 5 
animals were considered per group and one-way ANOVA / Tukey post hoc were 
performed. If not mentioned otherwise, experiments were performed in triplicates. 
Results
Aging decreases the capacity of MSCs to promote the generation of 
oligodendrocytes in vitro 
Soluble factors derived from yMSCs promote oligodendrocyte fate decision 
and differentiation at the expense of astrogenesis in tripotent NSCs (Rivera F.J. et 
al., 2006). To determine whether MSC aging affects their pro-oligodendrogenic 
activity, NSCs were incubated with conditioned media derived from yMSCs 
(yMSC-CM) as well as from oMSCs (oMSC-CM) and the oligodendrogenic effect 
Page 26 of 61
John Wiley & Sons, Inc.
GLIA
was evaluated. NSCs under control conditions showed a typical flat and star-like 
astrocytic morphology (Fig. 1A), while cells incubated in yMSC-CM and oMSC-CM 
displayed a multipolar oligodendroglial morphology with secondary branches (Fig. 
1E and I). Most of NSCs incubated under control conditions differentiated into glial 
fibrillary acidic protein (GFAP)-expressing astrocytes (Fig. 1B-D), whereas the 
majority of NSCs incubated in yMSC-CM as well as oMSC-CM give rise to myelin 
basic protein (MBP)-expressing oligodendrocytes (Fig. 1F-H and J-L, 
respectively). Both yMSC-CM and oMSC-CM decreased the proportion of GFAP-
expressing astrocytes with respect to the control condition to a similar extent (Fig. 
1N). Thus, regardless of donor age, soluble factors derived from MSCs are able to 
induce an oligodendrocyte fate at the expense of astrogenesis. However, although 
both yMSC-CM and oMSC-CM increased the proportion of MBP-expressing 
oligodendrocytes with respect to the control, yMSC-CM induced a higher 
percentage of MBP-positive cells than oMSC-CM in NSCs (Fig. 1M). 
Bioluminescence assays were used to confirm these findings. Although both 
yMSC-CM and oMSC-CM induced an increase in MBP promoter activity with 
respect to the control condition in a MSC-CM concentration-dependent manner 
(upon exposure to different MSC-CM dilutions), NSCs incubated with yMSC-CM 
displayed higher levels of luciferase activity compared to cells incubated in the 
presence of oMSC-CM (Fig. 1O and P). Since long-term in vitro expansion alters 
the MSCs’ growth rate (Suppl. Fig. 1A and B) as well as it induces senescence in 
many cell types (Baxter et al., 2004), we evaluated whether MSC long term culture 
expansion might affect the oligodendrogenic capacity of MSCs. Thus, NSCs were 
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exposed to conditioned medium obtained from MSCs of increasing passage 
number and MBP promoter activity was assessed by bioluminescence. 
Regardless of MSCs’ donor age, long-term in vitro expansion did not influence the 
MSCs derived oligodendrogenic activity, as MSC-CM harvested from cells with 
high and low passage number similarly induced MBP promoter activity (Suppl. Fig. 
1C and D). Overall, these results indicate that aging decreases the capability of 
MSCs to promote the generation of oligodendrocytes from NSCs.
As OPCs represent the major cellular source for remyelinating 
oligodendrocytes in the adult CNS (Zawadzka et al., 2010), we further asked 
whether young and old MSC were able to enhance OPC differentiation. Indeed, 
we have previously shown that MSCs-derived soluble factors enhance OPCs 
differentiation (Jadasz et al., 2013). Thus, OPCs were incubated for 2 and 4 days 
in the presence of yMSC-CM or oMSC-CM and differentiation was evaluated (Fig. 
2A-H). Sato based OPC media without growth factors was used as a control 
condition. Overall, independent of MSC donor’s age, soluble factors derived from 
MSCs increased the proportion of Olig2-expressing OPCs that differentiate into 
CNPase- and MBP-expressing oligodendrocytes when compared to control media 
(Fig. 2I-L). However, the yMSC-CM pro-oligodendrogenic effect on OPCs was 
more efficient compared to exposure with oMSC-CM exposure. When comparing 
with control media, 2 days of incubation with yMSC-CM was sufficient to induce an 
increase in the generation of CNP- and MBP-expressing oligodendrocytes, while 
this effect was only evident after 4 days of exposure to oMSC-CM (Fig. 2I-L). 
Moreover, the final proportion of CNP-expressing mature oligodendrocytes was 
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higher when OPCs were incubated with yMSC-CM compared to oMSC-CM (Fig. 
2J). yMSC-CM might also promote proliferation and/or survival in OPCs, thus, 
indirectly increasing the proportion mature oligodendrocytes rather than directly 
inducing OPC differentiation. To assess this possibility, we determined whether 
MSC-CM influences the percentage of Ki67+ and Caspase3+ cells during OPC 
differentiation. No difference between yMSC-CM and control conditions was 
observed (Suppl. Fig. 2A and B), indicating that yMSC-CM enhances the 
generation of oligodendrocytes by promoting OPC differentiation rather than 
interfering with cell proliferation or survival. Due to the lack of effect of yMSC-CM 
on OPC proliferation and survival, is very unlikely that MSC-CM obtained from old 
donors exert this effect. Therefore, oMSC-CM has a lower capacity to induce OPC 
differentiation compared to MSC-CM derived from young donors.
In summary both, young and aged MSCs can promote the generation of 
oligodendrocytes, although aged MSCs do so less successfully. 
 Aging suppresses the ability of MSC-CM to enhance ex vivo generation of 
myelin-like sheaths
Does the reduced oligodendrogenic activity of oMSCs might have a further 
consequence on CNS regeneration? Remyelination is highly efficient in young 
individuals, but this efficiency declines with aging (Shields, Gilson, Blakemore, & 
Franklin, 1999; Sim et al., 2002). Therefore, we next asked whether MSC derived 
soluble factors could not only increase OPC differentiation but also enhance 
myelination and, if so whether aging might affect this activity. To address these 
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questions we used a well-established ex vivo myelination model, where 
organotypic cerebellar slice cultures are shortly exposed to lysolecithin to provoke 
demyelination (Birgbauer et al., 2004; Jarjour, Zhang, Bauer, Ffrench-Constant, & 
Williams, 2012; Zhang, Jarjour, Boyd, & Williams, 2011). For this experiment, 
yMSC-CM and oMSC-CM were prepared exposing MSCs to basic organotypic 
slice culture medium and the unconditioned medium was used as control. Upon 
lysolecithin exposure, demyelinated slices were incubated in control medium, 
yMSC-CM or oMSC-CM and were collected at 2 and 6 days in vitro (DIV) post 
demyelination (Fig. 3A). Generation of myelin-like sheaths around the axons was 
determined by the ratio between the MBP/NF-H colocalization area (myelinated 
axons) and the total NF-H area (overall axons). This often equates to compact 
myelin formation in this model (Zhang et al., 2011). Slices exposed to yMSC-CM 
showed an increase in myelination when compared to control, while there was no 
difference between control and oMSC-CM treated slices (Fig. 3B). Hence, aging 
suppresses the ability of MSCs to stimulate the generation of oligodendrocytes and 
subsequent myelin-like sheath formation in an ex vivo model.
Aging interferes with the capacity of MSCs to enhance OPC differentiation 
during CNS remyelination in vivo
We further explored whether the age-related restriction in the ability of 
MSCs to promote the generation of oligodendrocytes and enhance remyelination 
is also observed in an in vivo context. We systemically transplanted, through the 
tail vein, 4.5 – 6.0 x 106 mCherry-expressing yMSCs or oMSCs in adult rats after 
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bilateral demyelination of the caudal cerebellar peduncles (CCP) (Fig. 4A and B) 
(Woodruff & Franklin, 1999). PBS intravenous administration was used as vehicle 
control. In this model, OPC differentiation occurs very efficiently in young animals, 
however, it is impaired with increasing age. Rats older than 12 months already 
display a reduced rate of OPC differentiation contributing to a significant delay in 
remyelination compared to young animals (< 3 months) (Shields et al., 1999; Sim 
et al., 2002). Therefore, middle age rats (12 months old) were used and sacrificed 
at 21 days post lesion to assess treatment efficiency. 
We used mCherry labeling to evaluate whether systemically transplanted 
MSCs survive and reach the lesion area and, most likely, exert a paracrine impact 
on neighboring CNS-resident cells. Following the mCherry signal, we found that 
transplanted MSCs were able to reach the demyelinating lesion (Fig. 4C). 
Regardless of the donor´s age we found approximately 65 +/- 25 mCherry-
expressing MSCs per 1 mm2 within the lesion area. Olig2 is expressed in all cells 
from the oligodendroglial lineage and we evaluated the expression of 
Adenomatous polyposis coli (APC) to distinguish between OPCs and differentiated 
oligodendrocytes. No difference was found among all groups in the total number 
of recruited Olig2+/APC- undifferentiated OPCs; however, only the animals that 
received yMSCs displayed a higher number of differentiated Olig2+/APC+ 
oligodendrocytes within the lesion site, while transplanted oMSCs exerted no 
significant effect on OPC differentiation (Fig. 4D and E). During remyelination, 
activated and proliferating OPCs can be detected by the expression of the 
transcription factor Nkx2.2 and Ki67, respectively (Watanabe, Hadzic, & 
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Nishiyama, 2004). Regardless of donor’s age, transplanted MSCs did not alter the 
number of Nkx2.2+ / Ki67+ proliferating OPCs (Suppl. Fig. 3A and B). These 
findings together suggest that MSCs increased the number of new 
oligodendrocytes generated by boosting OPC differentiation instead of indirectly 
enhancing OPC proliferation. As expected, none of the mCherry positive cell were 
found to co-express Olig2 (Suppl. Fig. 4), arguing against a transdifferentiation of 
transplanted MSCs to oligodendrocytes. 
During remyelination, OPC differentiation is favored by anti-inflammatory 
(M2) macrophages / microglia and inhibited by the presence of myelin debris 
(Miron et al., 2013). Therefore, we evaluated whether transplanted MSCs alter 
these particular properties that might indirectly influence OPC differentiation. 
Regardless of the donor’s age, transplanted MSCs did neither affect the number 
of Iba1+ macrophages / microglia present within the demyelinated lesion nor their 
M2 polarization revealed by the appearance of mannose receptor (MR)-expressing 
subpopulation (Fig. 5A and B). In addition, Oil Red O stainings, widely used to 
detect myelin debris in the lesion area (for example in (Ruckh et al., 2012)), 
revealed no effect on the clearance of myelin debris after MSCs treatments (Fig. 
5C and D). These data together with the previous in vitro findings suggest that 
transplanted MSCs directly exert their action on CNS-resident progenitor cells 
rather than modulating macrophages / microglia function and indirectly influencing 
OPCs differentiation. 
Finally, as OPC derived Schwann cells can also contribute to remyelination 
in the CNS (Zawadzka et al., 2010), we evaluated whether transplanted MSCs 
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influence this particular OPC feature. No changes were found in the number of 
Periaxin-positive cells, a well-established Schwann cell marker (Zawadzka et al., 
2010), in response to transplantation, indicating that MSCs do not alter OPC 
differentiation towards Schwann cells (Fig. 6A and B). No cross reaction between 
Periaxin and the inflammation marker Iba1 was observed (Suppl. Fig. 5), 
supporting the specificity of Periaxin to label Schwann cells. In summary, 
consistent with the previous in vitro and ex vivo findings, aging suppresses the 
capacity of transplanted MSCs to directly boost OPC differentiation and the further 
generation of new oligodendrocytes during in vivo remyelination.
Discussion
Aging affects homeostasis and reduces the regenerative capacity of various 
tissues and organs (Alt et al., 2012; Fulle et al., 2012; Ruckh et al., 2012). Besides 
systemic and local environmental cues, restrictions in the tissue-resident adult 
stem cells and their properties contribute to the age-related reduction in the 
regenerative potential. Here, we have shown that soluble factors derived from 
aged MSCs have a reduced ability to promote oligodendrogenesis in CNS stem 
and progenitor cells. It has been shown that aging influences the neurotrophic 
activity of MSCs (Brohlin, Kingham, Novikova, Novikov, & Wiberg, 2012), therefore 
it is likely that aged MSCs display a lower capacity to synthesize and/or release 
their yet unknown “oligodendrocyte differentiation factor(s)” when compared with 
MSCs derived from young donors.  Despite the presence of an oligodendrogenic 
activity, aged MSCs failed to boost OPC differentiation during remyelination. 
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Moreover, while yMSC were able to enhance the generation of myelin-like sheaths 
in an ex vivo model, oMSC lacked this capacity, suggesting that even if oMSCs 
are able to promote OPC differentiation in vitro their effect may be limited during 
in vivo remyelination. 
Aging decreases OPC differentiation and impairs endogenous CNS 
remyelination (R. J. Franklin & Ffrench-Constant, 2008; Shen et al., 2008; Shields 
et al., 1999; Sim et al., 2002). Nevertheless, in a previous study it has been shown 
that remyelination efficiency in old animals can be restored after exposure to a 
youthful systemic milieu via heterochronic parabiosis (Ruckh et al., 2012) or 
treatment with molecules such as 9-cis retinoic acid (Huang et al., 2011). Together, 
these observations suggest that age-related myelin regeneration restrictions can 
be overcome by the contribution of a strong regenerative microenvironment or 
stimulus. Here, we observed an enhancement in OPC differentiation during 
remyelination in middle aged CNS in response to systemic transplantation of 
MSCs obtained from young donors. Interestingly, even though only few 
transplanted cells reach the lesion area, this pro-regenerative effect exerted by 
MSCs might be supported by this fact that enables a closer interaction with CNS-
resident OPCs. These data suggest that transplanted MSCs might change the 
systemic and/or the CNS milieu exerting their oligodendrogenic activity and 
overcoming intrinsic age-related myelin repair limitations. However, similar to ex 
vivo myelination, aging abolishes this MSC pro-regenerative capacity as 
transplanted aged MSCs fail to boost OPC differentiation in the CNS of middle age 
recipients. 
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The age of 17 to 20 months for oMSCs was chosen for the following 
reasons: i) 17-20 months reflects approximately a human age that ranges between 
50 and 60 years, given the mean longevity of male Fischer 344 rats of 642 days 
(Chesky & Rockstein, 1976) and the mean life expectancy of the human male 
population of 69 years (“World Health Statistics 2016: Monitoring Health for the 
SDGs”. World Health Organization); ii) life expectancy of MS patients is 10 to 15 
years lower than that of the unaffected population (Compston & Coles, 2008), 
hence 55 to 60 years. Thus, we assume that 17 – 20 months old rats have a 
chronological / biological age of later stage MS patients, which are currently in the 
scope of MSC-MS trials. 
Since MSCs display immunomodulatory and neuroprotective activities, 
systemic autologous MSC therapy has been proposed for the treatment of MS 
(Connick et al., 2012; Freedman et al., 2010).  Here, we have shown for the first 
time that soluble factors derived from MSCs enhance ex vivo myelin-like sheath 
formation and that systemic MSCs transplantation boosts the generation of 
oligodendrocytes during CNS remyelination. Thus, this study strengthens the pro-
regenerative activity of MSCs and provides a further rationale for autologous MSC 
transplantation in MS therapy. In addition, and as an alternative strategy, a 
continuous pharmacological supply of the MSC-derived oligodendrogenic 
factor(s), which still need to be identified, could have a controlled and specific 
effect in the generation of new oligodendrocytes enhancing remyelination. 
However, this study argues on caution when developing this therapy for older MS 
patients as aging suppresses MSCs pro-oligodendrogenic activity. Thus, it clearly 
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urges for a careful revision when designing clinical MSC-based trials for MS 
treatment. The use of young-donor derived MSCs, for example umbilical cord 
derived MSCs, might be more efficient than autologous MSCs from elderly 
patients.  
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Figure Legends
Figure 1. Aged MSCs display a reduced ability to promote the generation of 
oligodendrocytes from NSCs. NSCs were incubated in control medium (MEM-
10%FBS, A-D) and MSC-CM derived from young MSCs (yMSC-CM, E-H) or old 
MSCs (oMSC-CM, I-L) for one week. Phase contrast images show NSCs 
morphology after the different treatments (A, E, I). Fluorescent images indicate 
NSCs expression of GFAP (B, F, J), MBP (C, G, K) and the merge (D, H, L). DAPI 
nuclear staining is shown in all fluorescent images. (A-L) Scale bar = 50 m. 
Quantitative analysis shows the percentage of MBP-expressing cells (M) and 
GFAP-expressing cells (N) for all conditions tested. Note that although both yMSC-
CM and oMSC-CM induce an increase in the proportion of MBP-expressing cells 
and a decrease in GFAP-expressing cells with respect to control. However, yMSC-
CM displays a higher effect on MBP-positive cells than oMSC-CM. Values are 
display as mean +/- SD. Experiment was performed in tetraplicate. One-way 
ANOVA and the Tukey post hoc-test were used for statistical analysis. ** p < 0.01; 
*** p < 0.001. NSCs were transfected with MBP promoter-Luci vector and 
incubated for 3 days under control medium, yMSC-CM and oMSC-CM. Cells were 
also exposed for 3 days to different MSC-CM dilutions. Quantification of 
bioluminescence data shows MBP promoter activation (as luciferase activity) in 
NSCs either treated in the conditions previously mentioned (O) or treated with 
increasing doses of yMSC-CM and oMSC-CM (P). Note that although both yMSC-
CM and oMSC-CM induce an increase of the MBP promoter activity with respect 
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to control, yMSC-CM displays a higher effect than oMSC-CM.  Values are display 
as mean +/- SD. Experiment was performed in triplicate. One-way ANOVA and the 
Tukey post hoc-test as well as two-way ANOVA (P) were used for statistical 
analysis. * p < 0.05; ** p < 0.01 (O) and p values given in graph title indicate 
significant difference between MSC-CM ages (P).
Figure 2. Aged MSCs display a reduced ability to promote OPC 
differentiation. Neonatal OPCs were incubated in control serum free Sato media 
(A and E) and yMSC (B and F) and oMSC (C and G) conditioned serum free Sato 
media for 2 and 4 days. Fluorescent images indicate the expression of 
differentiation CNP (red) and mature oligodendrocyte MBP (red) markers together 
with the pan oligodendrocyte lineage marker Olig2 (green). DAPI nuclear staining 
is shown in all fluorescent images.  Quantitative analysis shows the percentage of 
CNP-Olig2 (I and J) or MBP-Olig2 (K and L) double positive cells within the Olig2 
expressing cells at 2 and 4 days of incubation. Scale bars = 50µm. Note that both, 
yMSC-CM and oMSC increase OPC differentiation when compared to control. 
However, oMSC-CM displays a delayed and less effective activity in OPCs as is 
only evident at 4 days of incubation and not so pronounced when compare to 
yMSC-CM. Values are display as mean +/- SD. Experiments were done in 
triplicate. Statistics was performed by one-way ANOVA and the Tukey post hoc 
test. * p < 0.05; ** p < 0.01; *** p < 0.001.
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Figure 3. Soluble factors derived from yMSCs but not from oMSCs enhance 
myelin-like sheath formation ex vivo. Cerebellar slices from P9 rats were 
cultured ex vivo and exposed for 16 hours to lysolecithin to induce demyelination. 
Thereafter, demyelinated slices were incubated in control organotypic slice media, 
yMSC-CM and oMSC-CM for up to 6 days. Fluorescent images show the 
expression of Neurofilament H (red) as a marker of axons together with the mature 
oligodendrocyte marker MBP (green) present in the myelin-like sheaths, as an 
indicator of myelination at 2 and 6 days in vitro (DIV) after lysolecithin-induced 
demyelination (A). Scale bar = 100µm. Quantitative analysis shows the ratio 
between the area of the slice where NFH collocalizes with MBP and NFH area (B). 
Note that after 6 DIV only yMSC-CM enhances ex vivo myelin-like sheath 
formation while oMSC-CM leads to similar myelination levels when comparing to 
control condition. Values are display as mean +/- SD. Experiments are done in 
triplicate (duplicate for oMSC-CM). Statistic was performed by two-way ANOVA 
and Bonferroni post hoc test. P values in the graph title indicate significant 
difference between the conditions tested. * p < 0.05.
Figure 4. Only transplanted MSCs derived from young donors boost OPC 
differentiation during CNS remyelination. 12 months old rats were 
demyelinated by ethidium bromide injection into the caudal cerebellar peduncle 
(A). One, two and three days after demyelination, rats were systemically 
transplanted with yMSCs or oMSCs that express mCherry for their future detection 
(B). PBS is used as vehicle control. Fluorescent image shows the presence of 
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mCherry-expressing MSCs in the demyelinated area at 21 days post lesion (dpl) 
(C). Scale bar = 200µm. Fluorescent images show the presence of OPCs (Olig2+ 
/ APC-) and the generation of new oligodendrocytes (Olig2+ / APC+) in the lesion 
site of the different animal groups (D). Hoechst shows nuclei counterstaining. 
Dashed lines denote demyelinating lesion area (L). Scale bar = 100µm. In merge 
images, the inset shows a magnification of the area delimited by the square. 
Quantitative analysis shows the number of all oligodendroglial lineage cells 
(Olig2+), OPCs and differentiated oligodendrocytes within the demyelinated lesion 
area (mm2) of the distinct animal groups at 21 dpl (E). Note that only the animals 
that were transplanted with yMSCs display a higher number of differentiated 
oligodendrocytes (Olig2+/APC+) within the lesion site. Values are display as mean 
+/- SD. Five animals were analyzed for the PBS group while four animals were 
analyzed for the group transplanted either with yMSCs or oMSCs. Statistics was 
performed by one-way ANOVA and the Tukey post hoc test. * p < 0.05; NS: not 
significant.
Figure 5. Independently from donors age, transplanted MSCs do not alter 
macrophage / microglia response during CNS remyelination. 12 months old 
rats were demyelinated by ethidium bromide injection into the caudal cerebellar 
peduncle. One, two and three days after demyelination, rats were systemically 
transplanted with mCherry-expressing yMSCs or oMSCs. PBS is used as vehicle 
control. Fluorescent images show the lesion site of the different animal groups at 
21 dpl, the presence of macrophages / microglia (Iba1+) and their expression of 
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mannose receptor (MR+) evidencing M2 anti-inflammatory state (A). Hoechst 
shows nuclei counterstaining. Dashed lines denote demyelinating lesion area (L). 
Scale bar = 100µm. In merge images, the inset shows a magnification of the area 
delimited by the square. Quantitative analysis shows the number of macrophage / 
microglia cells (Iba1+) and the number of anti-inflammatory cells (MR+) within the 
lesion area (mm2) as well as the proportion of anti-inflammatory cells among the 
total macrophage / microglia cell population (MR+ / Iba1+) (B). Note that none of 
transplanted groups shows significant difference on the macrophage / microglia 
parameters measured respect to vehicle group. Phase contrast images show Oil 
Red O (ORO) staining to detect the presence of myelin debris within the lesion site 
in the different animal group at 21 dpl (C). Scale bar = 100µm. Quantification 
analysis show the mean relative ORO intensity per lesion area (mm2) (D). Note 
that none of transplanted groups shows significant difference on the clearance of 
myelin debris respect to vehicle group. Values are display as mean +/- SD. Five 
animals were analyzed for the PBS group while four animals were analyzed for the 
group transplanted either with yMSCs or oMSCs. Statistics was performed by one-
way ANOVA and the Tukey post hoc test. NS: not significant. 
Figure 6. Independently from donors age, transplanted MSCs do not alter the 
presence of Schwann cells during CNS remyelination. 12 months old rats were 
demyelinated by ethidium bromide injection into the caudal cerebellar peduncle. 
One, two and three days after demyelination, rats were systemically transplanted 
with mCherry-expressing yMSCs or oMSCs. PBS is used as vehicle control. 
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Fluorescent images show the lesion site of the different animal groups at 21 dpl 
and the presence of Schwann cells (A). Scale bar = 100µm. Hoechst shows nuclei 
counterstaining. Dashed lines denote demyelinating lesion area (L). Quantitative 
analysis shows the number of Periaxin-expressing cells presence within the lesion 
area (B). Note that none of transplanted groups shows significant difference on the 
number of Schwann cells presence within the lesion respect to vehicle group. 
Values are display as mean +/- SD. Five animals were analyzed for the PBS group 
while four animals were analyzed for the group transplanted either with yMSCs or 
oMSCs. Statistics was performed by one-way ANOVA and the Tukey post hoc test. 
NS: not significant. 
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Figure 1. Aged MSCs display a reduced ability to promote the generation of oligodendrocytes from NSCs. 
NSCs were incubated in control medium (MEM-10%FBS, A-D) and MSC-CM derived from young MSCs 
(yMSC-CM, E-H) or old MSCs (oMSC-CM, I-L) for one week. Phase contrast images show NSCs morphology 
after the different treatments (A, E, I). Fluorescent images indicate NSCs expression of GFAP (B, F, J), MBP 
(C, G, K) and the merge (D, H, L). DAPI nuclear staining is shown in all fluorescent images. (A-L) Scale bar 
= 50 m. Quantitative analysis shows the percentage of MBP-expressing cells (M) and GFAP-expressing 
cells (N) for all conditions tested. Note that although both yMSC-CM and oMSC-CM induce an increase in the 
proportion of MBP-expressing cells and a decrease in GFAP-expressing cells with respect to control. 
However, yMSC-CM displays a higher effect on MBP-positive cells than oMSC-CM. Values are display as 
mean +/- SD. Experiment was performed in tetraplicate. One-way ANOVA and the Tukey post hoc-test were 
used for statistical analysis. ** p < 0.01; *** p < 0.001. NSCs were transfected with MBP promoter-Luci 
vector and incubated for 3 days under control medium, yMSC-CM and oMSC-CM. Cells were also exposed for 
3 days to different MSC-CM dilutions. Quantification of bioluminescence data shows MBP promoter activation 
(as luciferase activity) in NSCs either treated in the conditions previously mentioned (O) or treated with 
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increasing doses of yMSC-CM and oMSC-CM (P). Note that although both yMSC-CM and oMSC-CM induce an 
increase of the MBP promoter activity with respect to control, yMSC-CM displays a higher effect than oMSC-
CM.  Values are display as mean +/- SD. Experiment was performed in triplicate. One-way ANOVA and the 
Tukey post hoc-test as well as two-way ANOVA (P) were used for statistical analysis. * p < 0.05; ** p < 
0.01 (O) and p values given in graph title indicate significant difference between MSC-CM ages (P). 
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Figure 2. Aged MSCs display a reduced ability to promote OPC differentiation. Neonatal OPCs were incubated 
in control serum free Sato media (A and E) and yMSC (B and F) and oMSC (C and G) conditioned serum free 
Sato media for 2 and 4 days. Fluorescent images indicate the expression of differentiation CNP (red) and 
mature oligodendrocyte MBP (red) markers together with the pan oligodendrocyte lineage marker Olig2 
(green). DAPI nuclear staining is shown in all fluorescent images.  Quantitative analysis shows the 
percentage of CNP-Olig2 (I and J) or MBP-Olig2 (K and L) double positive cells within the Olig2 expressing 
cells at 2 and 4 days of incubation. Scale bars = 50µm. Note that both, yMSC-CM and oMSC increase OPC 
differentiation when compared to control. However, oMSC-CM displays a delayed and less effective activity 
in OPCs as is only evident at 4 days of incubation and not so pronounced when compare to yMSC-CM. 
Values are display as mean +/- SD. Experiments were done in triplicate. Statistics was performed by one-
way ANOVA and the Tukey post hoc test. * p < 0.05; ** p < 0.01; *** p < 0.001. 
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Figure 3. Soluble factors derived from yMSCs but not from oMSCs enhance myelination ex vivo. Cerebellar 
slices from P9 rats were cultured ex vivo and exposed for 16 hours to lysolecithin to induce demyelination. 
Thereafter, demyelinated slices were incubated in control organotypic slice media, yMSC-CM and oMSC-CM 
for up to 6 days. Fluorescent images show the expression of Neurofilament H (red) as a marker of axons 
together with the mature oligodendrocyte marker MBP (green) present in the myelin sheaths, as an 
indicator of myelination at 2 and 6 days in vitro (DIV) after lysolecithin-induced demyelination (A). Scale bar 
= 100µm. Quantitative analysis shows the ratio between the area of the slice where NFH collocalizes with 
MBP and NFH area (B). Note that after 6 DIV only yMSC-CM enhances ex vivo myelination while oMSC-CM 
leads to similar myelination levels when comparing to control condition. Values are display as mean +/- SD. 
Experiments are done in triplicate (duplicate for oMSC-CM). Statistic was performed by two-way ANOVA and 
Bonferroni post hoc test. P values in the graph title indicate significant difference between the conditions 
tested. * p < 0.05. 
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Figure 4. Only transplanted MSCs derived from young donors boost OPC differentiation during CNS 
remyelination. 12 months old rats were demyelinated by ethidium bromide injection into the caudal 
cerebellar peduncle (A). One, two and three days after demyelination, rats were systemically transplanted 
with yMSCs or oMSCs that express mCherry for their future detection (B). PBS is used as vehicle control. 
Fluorescent image shows the presence of mCherry-expressing MSCs in the demyelinated area at 21 days 
post lesion (dpl) (C). Scale bar = 200µm. Fluorescent images show the presence of OPCs (Olig2+ / APC-) 
and the generation of new oligodendrocytes (Olig2+ / APC+) in the lesion site of the different animal groups 
(D). Hoechst shows nuclei counterstaining. Dashed lines denote demyelinating lesion area (L). Scale bar = 
100µm. In merge images, the inset shows a magnification of the area delimited by the square. Quantitative 
analysis shows the number of all oligodendroglial lineage cells (Olig2+), OPCs and differentiated 
oligodendrocytes within the demyelinated lesion area (mm2) of the distinct animal groups at 21 dpl (E). 
Note that only the animals that were transplanted with yMSCs display a higher number of differentiated 
oligodendrocytes (Olig2+/APC+) within the lesion site. Values are display as mean +/- SD. Five animals 
were analyzed for the PBS group while four animals were analyzed for the group transplanted either with 
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yMSCs or oMSCs. Statistics was performed by one-way ANOVA and the Tukey post hoc test. * p < 0.05; NS: 
not significant. 
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Figure 5. Independently from donors age, transplanted MSCs do not alter macrophage / microglia response 
during CNS remyelination. 12 months old rats were demyelinated by ethidium bromide injection into the 
caudal cerebellar peduncle. One, two and three days after demyelination, rats were systemically 
transplanted with mCherry-expressing yMSCs or oMSCs. PBS is used as vehicle control. Fluorescent images 
show the lesion site of the different animal groups at 21 dpl, the presence of macrophages / microglia 
(Iba1+) and their expression of mannose receptor (MR+) evidencing M2 anti-inflammatory state (A). 
Hoechst shows nuclei counterstaining. Dashed lines denote demyelinating lesion area (L). Scale bar = 
100µm. In merge images, the inset shows a magnification of the area delimited by the square. Quantitative 
analysis shows the number of macrophage / microglia cells (Iba1+) and the number of anti-inflammatory 
cells (MR+) within the lesion area (mm2) as well as the proportion of anti-inflammatory cells among the 
total macrophage / microglia cell population (MR+ / Iba1+) (B). Note that none of transplanted groups 
shows significant difference on the macrophage / microglia parameters measured respect to vehicle group. 
Phase contrast images show Oil Red O (ORO) staining to detect the presence of myelin debris within the 
lesion site in the different animal group at 21 dpl (C). Scale bar = 100µm. Quantification analysis show the 
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mean relative ORO intensity per lesion area (mm2) (D). Note that none of transplanted groups shows 
significant difference on the clearance of myelin debris respect to vehicle group. Values are display as mean 
+/- SD. Five animals were analyzed for the PBS group while four animals were analyzed for the group 
transplanted either with yMSCs or oMSCs. Statistics was performed by one-way ANOVA and the Tukey post 
hoc test. NS: not significant. 
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Figure 6. Independently from donors age, transplanted MSCs do not alter the presence of Schwann cells 
during CNS remyelination. 12 months old rats were demyelinated by ethidium bromide injection into the 
caudal cerebellar peduncle. One, two and three days after demyelination, rats were systemically 
transplanted with mCherry-expressing yMSCs or oMSCs. PBS is used as vehicle control. Fluorescent images 
show the lesion site of the different animal groups at 21 dpl and the presence of Schwann cells (A). Scale 
bar = 100µm. Hoechst shows nuclei counterstaining. Dashed lines denote demyelinating lesion area (L). 
Quantitative analysis shows the number of Periaxin-expressing cells presence within the lesion area (B). 
Note that none of transplanted groups shows significant difference on the number of Schwann cells presence 
within the lesion respect to vehicle group. Values are display as mean +/- SD. Five animals were analyzed 
for the PBS group while four animals were analyzed for the group transplanted either with yMSCs or oMSCs. 
Statistics was performed by one-way ANOVA and the Tukey post hoc test. NS: not significant. 
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Supplementary Figure 1. Regardless of the donors age, conditioned media derived from 
MSCs with different passages display a similar oligodendrogenic activity. Growth curve 
comparison between increasing passage numbers in yMSCs (A) as well in oMSCs (B). Note 
that long-term in vitro expansion influences MSCs growth rate. Quantification of 
bioluminescence data shows MBP promoter activation (as luciferase activity) in NSCs either 
under control conditions or exposed to conditioned medium from yMSCs (C) and oMSCs 
(D) from increasing passage numbers. Note that independently of the passage number, 
conditioned medium derived from MSCs similarly increase MBP promoter activity. Values 
are display as mean +/- SD. Experiments were performed in triplicate and two-way ANOVA 
was used for statistical analysis. The p values given in graph title indicate significant 
difference between the increasing MSCs passages (A and B). For bioluminescence assays, 
experiments were performed in triplicate and one-way ANOVA-Tukey post hoc was used 
for statistical analysis. * differences between passage 2 and passage 6; # differences between 
passage 2 and passage 4. ** o ## p < 0.01; *** o ### p < 0.001.
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Supplementary Figure 2. Soluble factors derived from yMSCs do not affect cell 
proliferation and survival during OPC differentiation. Differentiating OPCs were 
exposed to yMSC-CM and the proportion of proliferating and apoptotic cells was 
determined. At 0, 2, 4 and 6 days in vitro the percentage of Ki67+ (A) and Caspase 3+ (B) 
cells was determined to evaluate cell proliferation and survival, respectively. No differences 
were observed in OPCs exposed to yMSC-CM compared cells incubated under control 
conditions. NS: not significant.
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Supplementary Figure 3. Transplanted MSCs do not affect OPC activation and 
proliferation during CNS remyelination. 12 months old rats were demyelinated by 
ethidium bromide injection into the caudal cerebellar peduncle. One, two and three days after 
demyelination, yMSCs or oMSCs were systemically transplanted. PBS is used as vehicle 
control. Quantitative analysis shows the number of proliferating cells (Ki67+) (A) and the 
number of activated proliferating OPCs (Nkx2.2+ / Ki67) (B) within the lesion area (mm2) 
at 21 dpl. Note that none of transplanted groups shows significant difference on the number 
of proliferating cells and proliferating OPCs respect to the vehicle group. NS: not significant.
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Supplementary Figure 4. Transplanted MSCs do not transdifferentiate into cells from 
the oligodendroglial lineage during CNS remyelination. 12 months old rats were 
demyelinated by ethidium bromide injection into the caudal cerebellar peduncle. One, two 
and three days after demyelination, rats were systemically transplanted with yMSCs that 
express mCherry for their detection. Images show the presence of mCherry-expressing MSCs 
(red) as well as Olig2+ cells (green) at 21 dpl. Hoechst shows nuclei counterstaining (blue). 
Dashed lines denote demyelinating lesion area (L). Scale bar = 50µm. Inset in merge image 
shows a high magnification of the area limited by the square. Note that none of the 
transplanted mCherry-expressing MSCs co-express the oligodendrocyte lineage marker 
Olig2. 
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Supplementary Figure 5. Periaxin-positive Schwann Cells do not co-express 
the inflammatory cell marker Iba1 during CNS remyelination. 12 months old rats 
were demyelinated by ethidium bromide injection into the caudal cerebellar 
peduncle. Left panel shows the presence of Periaxin-expressing Schwann cells 
(green) and Iba1+ positive inflammatory cells (red) at 21 dpl. Hoechst shows nuclei 
counterstaining (blue).  Dashed lines denote demyelinating lesion area (L). Scale 
bar = 100µm.  Rest of the panels show a higher magnification of the area limited by 
the square. In merge image, the inset shows a magnification of the area delimited 
by the square. Note the absence of Periaxin-positive Schwann cells co-expressing 
the inflammatory cell marker Iba1. 
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Supplementary Movie. Confocal video showing the Z stacks of demyelinated cerebellar 
slices treated with yMSC-CM for 8 days. Myelin (MBP) is shown in red and axons (NFH) is 
shown in green. The video shows in detail how the myelin is ensheathing the axons.
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